Showing results (181-190 of 242) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|May 18, 2020
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trialMatthew D Galsky, José Ángel Arranz Arija, Aristotelis Bamias, et al.
European Urology|August 1, 2017
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewMichael Lardas, Matthew Liew, Roderick C van den Bergh, et al.
European Urology|May 22, 2023
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary FacultyAristotelis Bamias, Arnulf Stenzl, Stephanie L Brown, et al.
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
Critical Reviews in Oncology/Hematology|June 21, 2015
Prostate Cancer Unit Initiative in Europe: A position paper by the European School of OncologyRiccardo Valdagni, Hendrik Van Poppel, Michael Aitchison, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
European Urology|March 25, 2017
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines PanelPaul C Moldovan, Thomas Van den Broeck, Richard Sylvester, et al.
European Urology|May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate CancerThomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.
Rheumatology (Oxford, England)|September 30, 2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-lifeEnrico De Lorenzis, Gerlando Natalello, Greta Pellegrino, et al.
Pageof 25